We investigated and analysed the data regarding serum level of sFlt-1, previously described as a serum marker of endothelial dysfunction during bacterial sepsis and CA 15.3, analog of KL-6, for pulmonary fibrosis, in 262 patients affected by SARS-CoV-2 infection (Table 1). Here, MUC1 is linked to bacterial infectious disease with sepsis.